Skip to main content
OpenTrials
Completed

NCT Number: NCT05075239

Morbidity and Mortality in Solo Adult Traumatic Brain Injury Patients in Minia University Hospital

Tracking post-traumatic brain injury sequale

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Solo non penetrating neurotrauma victims

Exclusion criteria

  • 1- Penetrating head trauma. 2- Polytrauma patients. 3- Coexist of Psychiatric disorders or history of neuronal disorders. 4- Refusal of patient relatives to participate in the assignment. 5- Pregnant females with TBI. 6- Patients who died during 24 hours from admission to ICU . 7- Patients more than 65 years of age .

8- combined abdominal or orthopedic trauma.

Treatment and study plan

Primary outcomes

  1. mortality and morbidity

    Time frame: 4 weeks

    number of deaths from neurotrauma

Secondary outcomes

  1. prediction

    Time frame: one week

    to examine the predictors of outcome including age , gender , admission systolic blood pressure < 90 mmHg , GCS score ,APACHE II score ,lateralization of pupil , brain CT findings ,serum sodium &potassium ,mechanical ventilation and length of stay in ICU

Sponsors and collaborators

Lead sponsor

Minia University

Other

Registry information

Official study title

Incidence Of Morbidity And Mortality After Isolated Traumatic Brain Injury In Adult Neuro-intensive Care Unit In Minia University Hospital

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Oct 12, 2021
Registry last updated
Feb 4, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.